ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
MST Continus 10 mg, Tabletten retard - 10
44246002 Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch
MST Continus 10 mg, Tabletten retard29.03.1982
  01.05.2014
Morphine (N02AA01) 
WHO-DDD 
01.01.30.10
01.01.30. 
A+  
No 
IPCI
PR  
k.A.PR
  
7680442460025Synthetika
  
Composition
morphini sulfas pentahydricus 10 mg corresp. morphinum 7.52 mg, lactosum 90 mg, hydroxyethylcellulosum, alcohol cetylicus et stearylicus, magnesii stearas, talcum, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Morphine Sulfate Pentahydrate10 mg correspond Morphine 7.52 mg
BAG: Active AgentDose
Morphini Sulfas Pentahydricus (2:1)10 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Alcohol Cetylicus  
E 171 color.
E 172 color.
Hydroxyethylcellulosum  
Lactosum90 mg 
Macrogol3350  
Magnesii Stearas  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Stearylicus  
Talcum  
 
Source
Data was imported : 03.03.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home